20 / 28
Page 48
Day 2 December 08, 2017
Sessions 4
Cancer Biomarkers | Biomarkers & Immuno-Oncology | Biomarkers Detection & Discovery |
Clinical Biomarkers | Advances in Biomarkers Discovery
Session Chair
Topolcan Ondrej
Charles University, Czech Republic
Title:
Usage of metabolomics profile as biomarkers itself for diagnostic diseases
P G Lokhov,
Institute of Biomedical Chemistry, Russia
Title:
RhoGDI3, is this small molecular regulator key orchestring the movement and tumor mass in PDAC?
Mercedes Piedad de León-Bautista,
Central adn, Mexico
Title:
PHI and prostate cancer - optimal management
Topolcan Ondrej,
Charles University, Czech Republic
Title:
PEA3/ETV4-related transcription factors coupled with active ERK signalling are
associated with poor prognosis in gastric adenocarcinoma
Yeng S Ang,
Salford Royal University Hospital, UK
Title:
Novel biomarker proteins for cancer: Impact on diagnosis, prognosis and treatment
Varda Shoshan-Barmatz,
Ben-Gurion University of the Negev, Israel
Title:
Soarfenib effect on human colon cancer cells HCT116 and HCT116 p53-/-
M Al Hassan,
Beirut Arab University, Lebanon
Title:
Diagnostic and prognostic microRNAs in the serum of breast cancer patients
measured by droplet digital PCR
Sayda Omer Ebnaof,
University of Khartoum, Sudan
Title:
Association of human papilloma virus with head and neck cancer patients from Khyber
Pakhtunkhwa, Pakistan
Maimoona Sabir,
University of Haripur, Pakistan
Session Introduction